NCT00156806View on ClinicalTrials.gov

Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.

PHASE3CompletedINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2006

Conditions
Breast Cancer
Interventions
PROCEDURE

Aloe barbadensis topical application in a moisturizing cream vehicle.

Trial Locations (1)

T6G 1Z2

Cross Cancer Institute, Edmonton

All Listed Sponsors
lead

AHS Cancer Control Alberta

OTHER

NCT00156806 - Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer. | Biotech Hunter | Biotech Hunter